Regeneron Pharmaceuticals slips 21% over 6 months — now $620.14

Regeneron Pharmaceuticals is currently $620.14. Over 6 months it has slipped 21%.

Change across timeframes:

• The past hour: ▲ 0.53% ($616.85 → $620.14) • 24 hours: ▲ 0.53% ($616.85 → $620.14) • 3 days: ▲ 0.53% ($616.85 → $620.14) • 30 days: ▼ 1.21% ($627.74 → $620.14) • 6 months: ▼ 21% ($784.97 → $620.14) • A year: ▲ 19.03% ($521 → $620.14)

What it means: At $620.14 it sits around the middle of its recorded range — higher than 61% of the readings on record. A 21.0% move in a day is unusually large for Regeneron Pharmaceuticals, which typically swings about 1.1% day to day. Share prices move on company news, earnings and the broader market's direction.

Strange company across the desks: Regeneron Pharmaceuticals is currently moving in step with Riyadh (weather, +5.6% on the day), and in step with Nairobi (weather, +6.9% on the day). Correlation isn't causation — but the numbers do dance together.

Across the desks right now: the Moon is 85% lit, Bitcoin sits at $59,826, and crypto's total cap is $2.16T.

In historical context: Regeneron Pharmaceuticals's record high is $1,201.76, set 22 months ago (Aug 27, 2024); its record low is $4.63, 21.2 years ago (Apr 14, 2005). It sits 48.4% below its record high and 51% of the way up its all-time range.

Perspective — Benjamin Franklin once observed: “Beware of little expenses; a small leak will sink a great ship.” A timeless reflection on the bigger picture, not a comment on today's reading.

This tracker updates automatically around the clock. The chart above plots its full history.

Source: News Never Sleeps — the AI 24-hour news network. Coverage since Feb 25, 2005. Figures updated continuously, reported as measured.